{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:47:25Z","timestamp":1765295245101},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,20]]},"DOI":"10.7759\/cureus.17331","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T17:25:23Z","timestamp":1629480323000},"source":"Crossref","is-referenced-by-count":1,"title":["Once- Versus Twice-Daily Angiotensin-Converting Enzyme Inhibitors for Blood Pressure Control in Adult Patients With Hypertension"],"prefix":"10.7759","author":[{"given":"Kyle","family":"Fischer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandy","family":"Diec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"JNC8 guidelines for the management of hypertension in adults","volume":"90","author":"Armstrong C","year":"2014","unstructured":"Armstrong C. JNC8 guidelines for the management of hypertension in adults. Am Fam Physician. 2014, 90:503-504.","journal-title":"Am Fam Physician"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000152","article-title":"Heart disease and stroke statistics--2015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian D","year":"2015","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, et al.. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation. 2015, 131:29-322. 10.1161\/CIR.0000000000000152","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000065","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"71","author":"Whelton PK","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, et al.. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Hypertension. 2018, 71:13-115. 10.1161\/HYP.0000000000000065","journal-title":"Hypertension"},{"key":"ref4","article-title":"Angiotensin converting enzyme inhibitors (ACEI)","author":"Herman LL","year":"2021","unstructured":"Herman LL, Padala SA, Annamaraju P, Bashir K. Angiotensin converting enzyme inhibitors (ACEI). StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2021."},{"key":"ref5","article-title":"From kinetics to dynamics: are there differences between ACE inhibitors?","volume":"18","author":"Reid JL","year":"1997","unstructured":"Reid JL. From kinetics to dynamics: are there differences between ACE inhibitors?. Eur Heart J. 1997, 18:14-18.","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241030-00005","article-title":"Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update","volume":"41","author":"Song JC","year":"2002","unstructured":"Song JC, White CM. Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update. Clin Pharmacokinet. 2002, 41:207-224. 10.2165\/00003088-200241030-00005","journal-title":"Clin Pharmacokinet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/BF01857634","article-title":"Angiotensin converting enzyme inhibitors: comparative structure, pharmacokinetics, and pharmacodynamics","volume":"4","author":"Thind GS","year":"1990","unstructured":"Thind GS. Angiotensin converting enzyme inhibitors: comparative structure, pharmacokinetics, and pharmacodynamics. Cardiovasc Drugs Ther. 1990, 4:199-206. 10.1007\/BF01857634","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"288","author":"Furberg CD","year":"2002","unstructured":"Furberg CD, Wright JT Jr, Davis BR, et al.. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2002, 288:2981-2997. 10.1001\/jama.288.23.2981","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett NS","year":"2008","unstructured":"Beckett NS, Peters R, Fletcher AE, et al.. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008, 358:1887-1898. 10.1056\/NEJMoa0801369","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41371-020-00413-3","article-title":"Indian guidelines on hypertension-IV (2019): response to Dr. Pareek et al","volume":"35","author":"Shah SN","year":"2021","unstructured":"Shah SN, Munjal YP, Kamath SA, Wander GS. Indian guidelines on hypertension-IV (2019): response to Dr. Pareek et al. J Hum Hypertens. 2021, 35:751-752. 10.1038\/s41371-020-00413-3","journal-title":"J Hum Hypertens"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright JT Jr","year":"2015","unstructured":"Wright JT Jr, Williamson JD, Whelton PK, et al.. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015, 373:2103-2116. 10.1056\/NEJMoa1511939","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/0895-7061(95)00194-8","article-title":"Duration of action of angiotensin converting enzyme inhibitors","volume":"8","author":"Zannad F","year":"1995","unstructured":"Zannad F. Duration of action of angiotensin converting enzyme inhibitors. Am J Hypertens. 1995, 8:75-81. 10.1016\/0895-7061(95)00194-8","journal-title":"Am J Hypertens"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/0895-7061(96)00021-0","article-title":"Through\/peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonists","volume":"9","author":"Zannad F","year":"1996","unstructured":"Zannad F, Matzinger A, Larch\u00e9 J. Through\/peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonists. Am J Hypertens. 1996, 9:633-643. 10.1016\/0895-7061(96)00021-0","journal-title":"Am J Hypertens"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz754","article-title":"Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial","volume":"41","author":"Hermida RC","year":"2020","unstructured":"Hermida RC, Crespo JJ, Dom\u00ednguez-Sardi\u00f1a M, et al.. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. Eur Heart J. 2020, 41:4565-4576. 10.1093\/eurheartj\/ehz754","journal-title":"Eur Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3109\/07420528.2010.510230","article-title":"Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study","volume":"27","author":"Hermida RC","year":"2010","unstructured":"Hermida RC, Ayala DE, Moj\u00f3n A, Fern\u00e1ndez JR. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 2010, 27:1629-1651. 10.3109\/07420528.2010.510230","journal-title":"Chronobiol Int"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1081\/CEH-48762","article-title":"ACE inhibitors and chronotherapy","volume":"27","author":"Ohmori M","year":"2005","unstructured":"Ohmori M, Fujimura A. ACE inhibitors and chronotherapy. Clin Exp Hypertens. 2005, 27:179-185.","journal-title":"Clin Exp Hypertens"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2006.09.021","article-title":"Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure","volume":"59","author":"Hermida RC","year":"2007","unstructured":"Hermida RC, Ayala DE, Calvo C, Portaluppi F, Smolensky MH. Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure. Adv Drug Deliv Rev. 2007, 59:923-939. 10.1016\/j.addr.2006.09.021","journal-title":"Adv Drug Deliv Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1990.tb01848.x","article-title":"Once-daily lisinopril compared with twice-daily captopril in the treatment of mild to moderate hypertension: assessment of office and ambulatory blood pressures","volume":"30","author":"Whelton A","year":"1990","unstructured":"Whelton A, Miller WE, Dunne B Jr, Hait HI, Tresznewsky ON. Once-daily lisinopril compared with twice-daily captopril in the treatment of mild to moderate hypertension: assessment of office and ambulatory blood pressures. J Clin Pharmacol. 1990, 30:1074-1080. 10.1002\/j.1552-4604.1990.tb01848.x","journal-title":"J Clin Pharmacol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1993.tb01959.x","article-title":"Once-daily trandolapril compared with the twice-daily formulation in the treatment of mild to moderate essential hypertension: assessment by conventional and ambulatory blood pressures","volume":"33","author":"Poirier L","year":"1993","unstructured":"Poirier L, Bourgeois J, Lacourci\u00e8re Y. Once-daily trandolapril compared with the twice-daily formulation in the treatment of mild to moderate essential hypertension: assessment by conventional and ambulatory blood pressures. J Clin Pharmacol. 1993, 33:832-836. 10.1002\/j.1552-4604.1993.tb01959.x","journal-title":"J Clin Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199917110-00017","article-title":"A comparison of enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient compliance","volume":"17","author":"Girvin B","year":"1999","unstructured":"Girvin B, McDermott BJ, Johnston GD. A comparison of enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient compliance. J Hypertens. 1999, 17:1627-1631. 10.1097\/00004872-199917110-00017","journal-title":"J Hypertens"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1002174","article-title":"Assessment of single versus twice daily dosing of ramipril by ambulatory blood pressure monitoring in patients similar to those included in the HOPE study","volume":"21","author":"Goyal D","year":"2007","unstructured":"Goyal D, Chong AY, Watson RL, Prasad N, Watson RD. Assessment of single versus twice daily dosing of ramipril by ambulatory blood pressure monitoring in patients similar to those included in the HOPE study. J Hum Hypertens. 2007, 21:525-530. 10.1038\/sj.jhh.1002174","journal-title":"J Hum Hypertens"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1159\/000368513","article-title":"Treatment of hypertension: favourable effect of the twice-daily compared to the once-daily (evening) administration of perindopril and losartan","volume":"40","author":"Szauder I","year":"2015","unstructured":"Szauder I, Csaj\u00e1gi E, Major Z, Pavlik G, Ujhelyi G. Treatment of hypertension: favourable effect of the twice-daily compared to the once-daily (evening) administration of perindopril and losartan. Kidney Blood Press Res. 2015, 40:374-385. 10.1159\/000368513","journal-title":"Kidney Blood Press Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/jch.13011","article-title":"Efficacy and safety of twice- vs once-daily dosing of lisinopril for hypertension","volume":"19","author":"Tsai T","year":"2017","unstructured":"Tsai T, Kroehl ME, Smith SM, Thompson AM, Dai IY, Trinkley KE. Efficacy and safety of twice- vs once-daily dosing of lisinopril for hypertension. J Clin Hypertens (Greenwich). 2017, 19:868-873. 10.1111\/jch.13011","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000170138.56903.7a","article-title":"Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study","volume":"46","author":"Dolan E","year":"2005","unstructured":"Dolan E, Stanton A, Thijs L, et al.. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005, 46:156-161. 10.1161\/01.HYP.0000170138.56903.7a","journal-title":"Hypertension"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61538-4","article-title":"Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study","volume":"370","author":"Boggia J","year":"2007","unstructured":"Boggia J, Li Y, Thijs L, et al.. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007, 370:1219-1229. 10.1016\/S0140-6736(07)61538-4","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.04.043","article-title":"Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk","volume":"58","author":"Hermida RC","year":"2011","unstructured":"Hermida RC, Ayala DE, Moj\u00f3n A, Fern\u00e1ndez JR. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 2011, 58:1165-1173. 10.1016\/j.jacc.2011.04.043","journal-title":"J Am Coll Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.230","article-title":"Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease","volume":"171","author":"Minutolo R","year":"2011","unstructured":"Minutolo R, Agarwal R, Borrelli S, et al.. Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med. 2011, 171:1090-1098. 10.1001\/archinternmed.2011.230","journal-title":"Arch Intern Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000355","article-title":"Prognostic impact from clinic, daytime, and night-time systolic blood pressure in nine cohorts of 13,844 patients with hypertension","volume":"32","author":"Roush GC","year":"2014","unstructured":"Roush GC, Fagard RH, Salles GF, et al.. Prognostic impact from clinic, daytime, and night-time systolic blood pressure in nine cohorts of 13,844 patients with hypertension. J Hypertens. 2014, 32:2332-2340. 10.1097\/HJH.0000000000000355","journal-title":"J Hypertens"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy475","article-title":"Asleep blood pressure: significant prognostic marker of vascular risk and therapeutic target for prevention","volume":"39","author":"Hermida RC","year":"2018","unstructured":"Hermida RC, Crespo JJ, Otero A, et al.. Asleep blood pressure: significant prognostic marker of vascular risk and therapeutic target for prevention. Eur Heart J. 2018, 39:4159-4171. 10.1093\/eurheartj\/ehy475","journal-title":"Eur Heart J"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2011.04.003","article-title":"Circadian rhythms and cardiovascular health","volume":"16","author":"Portaluppi F","year":"2012","unstructured":"Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. Circadian rhythms and cardiovascular health. Sleep Med Rev. 2012, 16:151-166. 10.1016\/j.smrv.2011.04.003","journal-title":"Sleep Med Rev"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2015.142","article-title":"Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks","volume":"39","author":"Hermida RC","year":"2016","unstructured":"Hermida RC, Ayala DE, Smolensky MH, Fern\u00e1ndez JR, Moj\u00f3n A, Portaluppi F. Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks. Hypertens Res. 2016, 39:277-292. 10.1038\/hr.2015.142","journal-title":"Hypertens Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-018-0897-4","article-title":"Chronotherapy for hypertension","volume":"20","author":"Bowles NP","year":"2018","unstructured":"Bowles NP, Thosar SS, Herzig MX, Shea SA. Chronotherapy for hypertension. Curr Hypertens Rep. 2018, 20:97. 10.1007\/s11906-018-0897-4","journal-title":"Curr Hypertens Rep"},{"key":"ref33","unstructured":"Lisinopril. (2016). https.\/\/online.lexi.com\/."},{"key":"ref34","unstructured":"Ramipril. (2016). https.\/\/online.lexi.com\/."},{"key":"ref35","unstructured":"Enalapril. (2016). https.\/\/online.lexi.com\/."},{"key":"ref36","unstructured":"Benazepril. (2016). https.\/\/online.lexi.com\/."},{"key":"ref37","unstructured":"Captopril. (2016). https.\/\/online.lexi.com\/."},{"key":"ref38","unstructured":"Trandolapril. (2016). https.\/\/online.lexi.com\/."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/67864-once--versus-twice-daily-angiotensin-converting-enzyme-inhibitors-for-blood-pressure-control-in-adult-patients-with-hypertension","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:18Z","timestamp":1707507018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/67864-once--versus-twice-daily-angiotensin-converting-enzyme-inhibitors-for-blood-pressure-control-in-adult-patients-with-hypertension"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,20]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.17331","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,20]]}}}